Comparable stake leader
ALLIANCEBERNSTEIN L.P.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000924717.
Comparable stake leader
ALLIANCEBERNSTEIN L.P.
Disclosed value leader
ALLIANCEBERNSTEIN L.P.
Comparable rows
2/4
Latest evidence
31 Mar 2025
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
2 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ALLIANCEBERNSTEIN L.P. |
13D/G
|
5.9%
|
$24,971,008
849,354 shares
|
-$5,617,634 | 31 Mar 2025 |
| Beryl Capital Management LLC |
13D/G
|
1.7%
|
$6,984,970
237,584 shares
|
$0 | 31 Dec 2024 |
| Ronald B. Kalich Sr. |
3/4/5
Director
|
—
mixed-class rows
|
$1,177,049
42,131 shares
mixed-class rows
|
— | 08 Feb 2024 |
| Nusrath Sultana |
3/4/5
VP, Clinical Affairs
|
—
class O/S missing
|
$221,824
6,530 shares
|
— | 12 Feb 2022 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Jun 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-13 of 13 reporting-owner rows connected to SURMODICS INC. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ronald B. Kalich Sr. | Director | $1,177,049 | Mixed | 08 Feb 2024 | ||
| Nusrath Sultana | VP, Clinical Affairs | $221,824 | Mixed | 12 Feb 2022 | ||
| Jose H. Bedoya | Director | $0 | Mixed | 19 Nov 2025 | ||
| Charles W. Olson | SVP, Medical Device Coatings | $0 | Mixed | 19 Nov 2025 | ||
| Timothy J. Arens | Chief Financial Officer | $0 | Mixed | 19 Nov 2025 | ||
| Gary R. Maharaj | President & CEO, Director | $0 | Mixed | 19 Nov 2025 | ||
| Lisa Heine Wipperman | Director | $0 | Mixed | 19 Nov 2025 | ||
| John D. Manders | VP Finance, Corp. Controller | $0 | Mixed | 19 Nov 2025 | ||
| Gordon S. Weber | Sr. VP of Legal, GC and Sec. | $0 | Mixed | 19 Nov 2025 | ||
| David R. Dantzker | Director | $0 | Mixed | 19 Nov 2025 | ||
| Teri Woodwick Sides | SVP, Vascular Interventions | $0 | Mixed | 19 Nov 2025 | ||
| Joseph J. Stich | SVP of HR, President IVD | $0 | Mixed | 19 Nov 2025 | ||
| Susan E. Knight | Director | $0 | Mixed | 19 Nov 2025 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles W. Olson | SRDX | Common Stock | Disposed to Issuer | -100% | -800 | 0 | 19 Nov 2025 | By IRA | ||
| Charles W. Olson | SRDX | Common Stock | Disposed to Issuer | -100% | -51,478 | 0 | 19 Nov 2025 | Direct | ||
| Charles W. Olson | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -99,796 | 0 | 19 Nov 2025 | Direct | ||
| John D. Manders | SRDX | Common Stock | Disposed to Issuer | -100% | -8,155 | 0 | 19 Nov 2025 | Direct | ||
| John D. Manders | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -16,156 | 0 | 19 Nov 2025 | Direct | ||
| Gordon S. Weber | SRDX | Common Stock | Disposed to Issuer | -100% | -21,040 | 0 | 19 Nov 2025 | Direct | ||
| Gordon S. Weber | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -76,322 | 0 | 19 Nov 2025 | Direct | ||
| Gordon S. Weber | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -11,538 | 0 | 19 Nov 2025 | Direct | ||
| Teri Woodwick Sides | SRDX | Common Stock | Disposed to Issuer | -100% | -34,703 | 0 | 19 Nov 2025 | Direct | ||
| Teri Woodwick Sides | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -17,883 | 0 | 19 Nov 2025 | Direct | ||
| Teri Woodwick Sides | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -118,562 | 0 | 19 Nov 2025 | Direct | ||
| David R. Dantzker | SRDX | Common Stock | Disposed to Issuer | -100% | -40,183 | 0 | 19 Nov 2025 | Direct | ||
| David R. Dantzker | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -2,964 | 0 | 19 Nov 2025 | Direct | ||
| David R. Dantzker | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -18,905 | 0 | 19 Nov 2025 | Direct | ||
| Lisa Heine Wipperman | SRDX | Common Stock | Disposed to Issuer | -100% | -13,978 | 0 | 19 Nov 2025 | Direct | ||
| Lisa Heine Wipperman | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -2,964 | 0 | 19 Nov 2025 | Direct | ||
| Lisa Heine Wipperman | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -18,905 | 0 | 19 Nov 2025 | Direct | ||
| Susan E. Knight | SRDX | Common Stock | Disposed to Issuer | -100% | -37,240 | 0 | 19 Nov 2025 | Direct | ||
| Susan E. Knight | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -3,196 | 0 | 19 Nov 2025 | Direct | ||
| Susan E. Knight | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -20,932 | 0 | 19 Nov 2025 | Direct | ||
| Jose H. Bedoya | SRDX | Common Stock | Disposed to Issuer | -100% | -30,008 | 0 | 19 Nov 2025 | Direct | ||
| Jose H. Bedoya | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -2,964 | 0 | 19 Nov 2025 | Direct | ||
| Jose H. Bedoya | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -18,905 | 0 | 19 Nov 2025 | Direct | ||
| Timothy J. Arens | SRDX | Common Stock | Disposed to Issuer | -100% | -67,299 | 0 | 19 Nov 2025 | Direct | ||
| Timothy J. Arens | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -17,883 | 0 | 19 Nov 2025 | Direct | ||
| Timothy J. Arens | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -98,837 | 0 | 19 Nov 2025 | Direct | ||
| Joseph J. Stich | SRDX | Common Stock | Disposed to Issuer | -100% | -61,631 | 0 | 19 Nov 2025 | Direct | ||
| Joseph J. Stich | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -17,883 | 0 | 19 Nov 2025 | Direct | ||
| Joseph J. Stich | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -85,641 | 0 | 19 Nov 2025 | Direct | ||
| Gary R. Maharaj | SRDX | Common Stock | Disposed to Issuer | -100% | -192,056 | 0 | 19 Nov 2025 | Direct | ||
| Gary R. Maharaj | SRDX | Employee Stock Options (right to buy) | Disposed to Issuer | -100% | -74,515 | 0 | 19 Nov 2025 | Direct | ||
| Gary R. Maharaj | SRDX | Employee Stock Option (right to buy) | Disposed to Issuer | -100% | -354,892 | 0 | 19 Nov 2025 | Direct |